课题基金 / 基金详情

项目摘要

项目成果

Jordi Ochando的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT The Tisch Cancer Institute (TCI) Flow Cytometry Shared Resource Facility (FCSRF) provides TCI members with access to state-of-the-art technology and expertise for the successful development of scientific research projects. Flow cytometry is a powerful technology that enables researchers to study simultaneous multiparametric characteristics of thousands of cells per second to decipher complex cellular and molecular processes in health and disease. The FCSRF comprises the institutional Flow Cytometry Core and two TCI satellite sites. The FCSRF is equipped with six analyzers and six cell sorters contained in biosafety level 2+ areas dedicated to isolate non-fixed human samples and mouse cells infected with class II pathogens. In addition, two satellite sites are equipped with four analyzers. Staffed with seven flow cytometry specialists committed at 100% to this facility, the SRF provides operational, training, and consultation services covering all aspects of flow cytometry including fundamental cell biology principles, analyses, isolation single cells from cancer patients, and identification of over thirty different cell surface/intracellular antigens on the same cell using the revolutionary Aurora platform. The FCSRF also offers services for fundamental applications, such as single cell isolation, to support innovative and complex biological studies involving RNA-seq, ChIP-seq, ATAC- seq, and CITE-seq together with proteomics, metabolomics, and lipidomics profiling. With this in mind, our mission is to provide the necessary instrumentation and expertise regarding flow cytometry analyses and cell sorting so that TCI laboratories improve human cancer knowledge, diagnosis, and treatment through basic sciences, translational, and clinical research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanistic and Bioinformatics Core
Myeloid Specific Targeted Nanoimunotherapy for Organ Transplant Acceptance
Myeloid Specific Targeted Nanoimunotherapy for Organ Transplant Acceptance
Flow Cytometry
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究